Two Sigma Advisers
CRMD icon

Two Sigma Advisers’s CorMedix CRMD Stock Holding History

Two Sigma Advisers’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,200
Closed -$247K – 507
2025
Q4 		$247K Buy
21,200
+7,000
+49% +$77.4K ﹤0.01% 2046
2025
Q3 		$165K Buy
+14,200
New +$172K ﹤0.01% 2169
2023
Q4 		– Sell
-51,900
Closed -$192K – 2524
2023
Q3 		$192K Buy
51,900
+37,900
+271% +$151K ﹤0.01% 2105
2023
Q2 		$55.5K Sell
14,000
-34,600
-71% -$171K ﹤0.01% 2266
2023
Q1 		$201K Buy
48,600
+3,100
+7% +$12.7K ﹤0.01% 2266
2022
Q4 		$192K Sell
45,500
-8,400
-16% -$29.7K ﹤0.01% 2202
2022
Q3 		$153K Sell
53,900
-37,200
-41% -$155K ﹤0.01% 2253
2022
Q2 		$366K Buy
91,100
+42,200
+86% +$157K ﹤0.01% 2055
2022
Q1 		$268K Sell
48,900
-34,600
-41% -$158K ﹤0.01% 2274
2021
Q4 		$380K Sell
83,500
-75,500
-47% -$375K ﹤0.01% 2047
2021
Q3 		$739K Sell
159,000
-44,300
-22% -$258K ﹤0.01% 1756
2021
Q2 		$1.4M Buy
203,300
+25,600
+14% +$204K ﹤0.01% 1482
2021
Q1 		$1.77M Sell
177,700
-36,300
-17% -$382K ﹤0.01% 1323
2020
Q4 		$1.59M Buy
214,000
+91,900
+75% +$625K ﹤0.01% 1373
2020
Q3 		$736K Buy
122,100
+108,300
+785% +$544K ﹤0.01% 1643
2020
Q2 		$87K Buy
+13,800
New +$63.9K ﹤0.01% 2376
2019
Q1 		– Sell
-2,240
Closed -$14K – 2322
2018
Q4 		$14K Buy
+2,240
New +$15K ﹤0.01% 2322

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Advisers's CRMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 21,200 shares — an estimated $247K sold.

Two Sigma Advisers first reported a position in CRMD in Q4 2018 and held it in 17 quarters. The position peaked at $1.77M in Q1 2021. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Two Sigma Advisers reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 21,200 CorMedix shares in Q1 2026, an estimated $247K.
  • Two Sigma Advisers first reported a position in CorMedix in Q4 2018 and held it in 17 quarters.
  • Two Sigma Advisers's CorMedix position peaked at $1.77M in Q1 2021.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.